Effective site selection is critical to study feasibility, recruitment success, and on-time execution. CRS provides structured, data-driven site selection support to ensure that clinical trials are placed at sites with the appropriate experience, infrastructure, and patient access to meet protocol requirements.

We assess potential sites based on therapeutic experience, operational capacity, staffing availability, facility suitability, and historical performance. Our evaluation includes feasibility questionnaires, investigator interviews, and review of prior study metrics to confirm realistic enrollment projections and operational readiness. Particular attention is given to protocol complexity, dosing requirements, safety oversight, and visit schedules, especially for early-phase and first-in-human studies.

CRS supports sponsors throughout the full site selection process, from initial long-list development to final site confirmation. We coordinate site outreach, manage feasibility data collection, and provide comparative analyses to support informed decision-making. Our team ensures that selected sites align with regulatory expectations, ethics requirements, and study timelines.

Once sites are selected, we facilitate a smooth transition into study start-up by supporting contract and budget discussions, investigator documentation collection, and site readiness activities. Close collaboration with sponsors and investigators ensures alignment on expectations, timelines, and responsibilities from the outset.

By applying a pragmatic and experience-based approach, CRS helps minimize start-up delays, reduce recruitment risk, and establish a strong operational foundation for successful clinical trial execution.

‍